Published in ACS Nano on July 29, 2016
Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J (1978) 5.40
Heparin and heparan sulfate: structure and function. Nat Prod Rep (2002) 2.85
Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther (1993) 1.98
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology (2007) 1.97
A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res (2005) 1.83
Nonviral gene delivery: principle, limitations, and recent progress. AAPS J (2009) 1.69
In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol Ther (2012) 1.59
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta (2007) 1.56
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J Biol Chem (1998) 1.21
In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine (2010) 1.09
Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol (2009) 1.09
Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol (2011) 1.09
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res (2006) 1.02
Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials (2009) 1.02
Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J Drug Target (2000) 1.00
Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes. Mol Pharm (2009) 1.00
A method for the estimation of polyethylene glycol in plasma protein fractions. Anal Biochem (1980) 0.99
Lipid and polymeric carrier-mediated nucleic acid delivery. Expert Opin Drug Deliv (2010) 0.99
Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther (2000) 0.99
A colorimetric assay for chemical heparin in plasma. Anal Biochem (1982) 0.94
Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials (2010) 0.90
Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles. J Control Release (2012) 0.88
Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection. J Drug Target (2013) 0.86
Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Invest Radiol (2013) 0.86
Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J Control Release (2007) 0.85
Systemic tumor-specific gene delivery. J Control Release (2013) 0.84
Design, preparation and application of nucleic acid delivery carriers. Biotechnol Adv (2013) 0.82
PEGylated cationic nanoemulsions can efficiently bind and transfect pIDUA in a mucopolysaccharidosis type I murine model. J Control Release (2015) 0.81
Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model. J Pharm Sci (2012) 0.80
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression. Gene Ther (2014) 0.80
Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett (2002) 0.79